252 publications
Belimumab (Benlysta®) for the treatment of adult patients with auto-antibody-positive systemic lupus erythematosus (SLE)
Zorginstituut Nederland has carried out an assessment of the medicinal product subcutaneous belimumab (Benlysta®) and a ...
Fampridine (Fampyra®) in cases of multiple sclerosis (MS)
Zorginstituut Nederland carried out an assessment of the medicinal product fampridine (Fampyra®). Based on the outcomes of the ...
Nusinersen (Spinraza®) for the treatment of 5q Spinal Muscular Atrophy
Zorginstituut Nederland carried out an assessment on the medicinal product nusinersen (Spinraza®) for the treatment of 5q Spinal ...
Evolocumab (Repatha®) for the treatment of hypercholeresterolaemia
Zorginstituut Nederland issued a package advice on the medicinal product evolocumab (Repatha®) for the treatment of ...
Cysteamine eyedrops (Cystadrops®) for the treatment of cystinosis
Zorginstituut Nederland carried out an assessment of the medicinal product cysteamine (Cystadrops®). The viscous cysteamine HCL ...
Zinnige Zorg room for improvement report - Chest pain (Suspected) Stable Angina Pectoris
Zorginstituut Nederland’s motto is "Taking care of good health care: no more and no less than necessary". Every citizen must be ...
Zinnige Zorg room for improvement report - Appropriate use of expensive medicines in cases of metastatic renal cell carcinoma
Within the framework of the Zinnige Zorg Programme, Zorginstituut Nederland systematically assesses the Dutch minimal and ...
Idebenone (Raxone®) for the treatment of Leber’s Hereditary Optic Neuropathy (LHON)
Zorginstituut Nederland has carried out an assessment of the medicinal product idebenone (Raxone®). Idebenone (Raxone®) is not ...